These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 29356802)
1. 3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B. Luo J; Wang K; Li GS; Lei DQ; Huang YJ; Li WD; Chen YQ; Kong JL Med Sci Monit; 2018 Jan; 24():427-437. PubMed ID: 29356802 [TBL] [Abstract][Full Text] [Related]
2. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Rajendran R; Mowat E; Jones B; Williams C; Ramage G Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638 [TBL] [Abstract][Full Text] [Related]
3. Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid. Kvasničková E; Paulíček V; Paldrychová M; Ježdík R; Maťátková O; Masák J World J Microbiol Biotechnol; 2016 Nov; 32(11):187. PubMed ID: 27660214 [TBL] [Abstract][Full Text] [Related]
4. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods. Bugli F; Posteraro B; Papi M; Torelli R; Maiorana A; Paroni Sterbini F; Posteraro P; Sanguinetti M; De Spirito M Antimicrob Agents Chemother; 2013 Mar; 57(3):1275-82. PubMed ID: 23263007 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim. Kirchhoff L; Dittmer S; Furnica DT; Buer J; Steinmann E; Rath PM; Steinmann J J Antimicrob Chemother; 2022 May; 77(6):1645-1654. PubMed ID: 35289361 [TBL] [Abstract][Full Text] [Related]
6. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968 [TBL] [Abstract][Full Text] [Related]
8. In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm. Zeng R; Li M; Chen Q; Wang L; Zhan P; Wang C; Lv G; Shen Y; Liu W Antimicrob Agents Chemother; 2014; 58(3):1443-50. PubMed ID: 24342649 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus. Krishnan S; Manavathu EK; Chandrasekar PH J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093 [TBL] [Abstract][Full Text] [Related]
10. Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus. Zhao Y; Paderu P; Park S; Dukhan A; Senter M; Perlin DS Antimicrob Agents Chemother; 2012 May; 56(5):2770-2. PubMed ID: 22314535 [TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole. Amarsaikhan N; Albrecht-Eckardt D; Sasse C; Braus GH; Ogel ZB; Kniemeyer O Int J Med Microbiol; 2017 Oct; 307(7):398-408. PubMed ID: 28811086 [TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M; Farag N; Khardori N Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806 [TBL] [Abstract][Full Text] [Related]
13. Effect of serum components on biofilm formation by Aspergillus fumigatus and other Aspergillus species. Wuren T; Toyotome T; Yamaguchi M; Takahashi-Nakaguchi A; Muraosa Y; Yahiro M; Wang DN; Watanabe A; Taguchi H; Kamei K Jpn J Infect Dis; 2014; 67(3):172-9. PubMed ID: 24858605 [TBL] [Abstract][Full Text] [Related]
14. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838 [TBL] [Abstract][Full Text] [Related]
16. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B. Gautam P; Shankar J; Madan T; Sirdeshmukh R; Sundaram CS; Gade WN; Basir SF; Sarma PU Antimicrob Agents Chemother; 2008 Dec; 52(12):4220-7. PubMed ID: 18838595 [TBL] [Abstract][Full Text] [Related]
17. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. Mowat E; Butcher J; Lang S; Williams C; Ramage G J Med Microbiol; 2007 Sep; 56(Pt 9):1205-1212. PubMed ID: 17761484 [TBL] [Abstract][Full Text] [Related]
18. Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm. Nazik H; Penner JC; Ferreira JA; Haagensen JA; Cohen K; Spormann AM; Martinez M; Chen V; Hsu JL; Clemons KV; Stevens DA Antimicrob Agents Chemother; 2015 Oct; 59(10):6514-20. PubMed ID: 26239975 [TBL] [Abstract][Full Text] [Related]
19. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays. Kiraz N; Oz Y; Dag I Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374 [TBL] [Abstract][Full Text] [Related]
20. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay. Wetter TJ; Hazen KC; Cutler JE Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]